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Mammalian sGC is a heterodimer composed of - and -
subunits (Figure 1). The C-terminus of each subunit con-
tains a catalytic domain and the active site is composed of
residues from both subunits. The catalytic domains also
form a pseudosymmetric active site that contains residues
known to be involved in nucleotide binding, but lack the
amino acids required for catalysis. Sequence analysis
shows that each subunit also contains well-defined PAS-
like domain, and a predicted helical region. The N-termini
of the - and -subunits are homologous to the H-NOX
(Heme-Nitric oxide/OXygen) family of proteins. The N-
terminus of -subunit contains a ferrous heme cofactor
that serves a receptor for NO. sGC activity is also modu-
lated by ATP and the substrate GTP and recent studies
point toward a more complicated role for NO in the regu-
lation of activity. Structural results coupled with biochem-
ical and cellular experiments have broadened the current
molecular view of the regulation of sGC.
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Domain structure of sGC Figure 1
Domain structure of sGC.